New Way to Dose Buprenorphine

April 20th, 2017

A new subcutaneous injection form of buprenorphine has been developed by Swedish pharmaceutical company Camarus and has shown promise in clinical trials. The liquid substance containing buprenorphine forms a gel once injected and can be easily administered through subcutaneous injection at weekly or monthly intervals. In a recent blog post, Dr. Jana Burson discusses this potential new option for administering buprenorphine.

Read Post

Posted in Content

A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.